Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Lindus Therapeutics seeks a Senior Director of Biostatistics to own statistical strategy across a growing asset portfolio. You will be hands-on leading statistics on live programmes from protocol development to database lock and CSR, while shaping team direction and processes.
You’ll collaborate with clinical, regulatory, data, and business teams to align study design with regulatory expectations and deal terms, building a scalable biostatistics function as Lindus expands its portfolio.
Great science regularly stalls in the clinic, not because the science is wrong, but because the company behind it lacks the capital, infrastructure, or focus to take it all the way through. Today’s clinical-stage biopharma model is broken, and as a result promising treatments never reach patients.
Great science regularly stalls in the clinic, not because the science is wrong, but because the company behind it lacks the capital, infrastructure, or focus to take it all the way through. Today’s clinical-stage biopharma model is broken, and as a result promising treatments never reach patients.
Our mission is to fix this: we’re building the next generation of biopharma by in-licensing clinical-stage therapeutic assets and developing them through Lindus Health’s integrated, technology-first clinical trial infrastructure. We’re a new initiative, but we’re building on a proven foundation - the same infrastructure that has delivered 82% of Lindus Health’s sponsor trials on or ahead of timeline, across 40+ completed trials across the US and Europe.
We’re in-licensing 5-7 clinical-stage, typically Phase-2-ready assets, funded directly from Lindus Health’s balance sheet. We’re targeting deal close on our first assets through 2026, with first trials launching in H1 2027.
As Lindus Therapeutics builds out its portfolio through in-licensing, biostatistics sits at the centre of nearly every decision that follows - which assets are worth pursuing, how trials are designed, and what evidence ultimately reaches regulators. The Senior Director of Biostatistics owns statistical strategy across that growing portfolio and, given the size of the team today, stays hands-on personally leading the statistics on live programmes from protocol development through database lock and clinical study report. This is very much a coach-player role to start: as much applied biostatistician as leader, willing to roll up your sleeves alongside setting the team’s direction.
This role matters because the statistical rigour of an incoming asset's data package directly shapes deal terms and development risk - without a strong statistical voice at the table during due diligence, weak signals get missed and genuinely promising ones get under-valued. It’s also Lindus Therapeutics' primary statistical interface with regulators, so the credibility of every regulatory interaction rests on this seat.
You’ll work closely with the clinical and medical teams on endpoint selection and trial design, with data architecture and clinical operations to align statistics with study execution, and alongside clinical, regulatory, and business development colleagues in due diligence discussions on prospective in-licensing targets. You’ll also build out the biostatistics, statistical programming, and medical writing functions as the portfolio grows, and set the team’s processes and standards as you go.
Make an impact across all areas of our business and fix one of the world's most broken industries.
We are an equal opportunity employer committed to building a diverse and inclusive workforce. We evaluate all candidates based solely on their skills, experience, and qualifications relevant to the role. We do not discriminate on the basis of race, ethnicity, religion, gender, gender identity, sexual orientation, age, disability, veteran status, or any other legally protected status